February 19, 2022 Comments Off on New patent for Vifor Fresenius drug VELPHORO Posted in: Patent Added Annual Drug Patent Expirations for VELPHORO Velphoro is a drug marketed by Vifor Fresenius and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Vifor Fresenius drug VELPHORO appeared first on Dr…
February 19, 2022 Comments Off on New tentative approval for Zydus Pharms drug roflumilast Posted in: Tentative Approval Roflumilast is the generic ingredient in two branded drugs marketed by Astrazeneca, Breckenridge, Hetero Labs Ltd Iii, Micro Labs, Mylan, Strides Pharma, and Torrent and, and is included in seven…
The post New tentative approval for Zydus Pharms drug r…
